Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Medtronic Closes Acquisition of Ear, Nose, and Throat MedTech Firm Intersect ENT.

Document Cited in Related
Vincent

MANews-(C)2009-2022

Dublin-based healthcare technology company Medtronic plc (NYSE: MDT) has completed the acquisition of ear, nose, and throat (ENT) medical technology specialist Intersect ENT, the company said.

This deal was announced last August, when Medtronic agreed acquire all outstanding shares of Intersect ENT for USD 28.25 per share in an all-cash transaction implying an enterprise value of approximately USD 1.1bn.

Medtronic said the deal expands its ear, nose, and throat portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.

As a result of the close of the transaction announced on Aug. 6, 2021, Medtronic has acquired Intersect ENT's Propel and Sinuva (mometasone furoate) sinus implant product lines and technology, intellectual property, and Menlo Park, Calif., facility.

Intersect ENT employees also join Medtronic through this acquisition.

A former Intersect ENT brand, Fiagon, was divested simultaneously at close, and those products â[euro]* Cube navigation system and VenSure balloon sinus dilation system â[euro]* were not included in the acquisition.

Intersect ENT's product lines and customer base will further the efforts of Medtronic to have a positive impact for patients who suffer from chronic rhinosinusitis.

CRS is one of the most common health care problems in the U.S., with approximately 30m adults diagnosed annually...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT